Study of ME-401 in Subjects With Relapsed or Refractory Indolent B-cell Non-Hodgkin's Lymphoma
Clinical trial NCT03985189 · COMPLETED
Trial details
- NCT number
- NCT03985189
- Sponsor
- Kyowa Kirin Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-04-29
- Primary completion
- 2025-01-15
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.